Closed SME IPO ABH

ABH Healthcare IPO GMP & Allotment

ABH Healthcare operates a 150-bed multi-specialty tertiary care hospital in Ferozepur, Punjab, under the brand “Anil Baghi Hospital.” The company focuses on providing a wide range of healthcare services, including advanced clinical care across approximately 25 specialties. Core disciplines include cardiac sciences, neurology, minimally invasive spine and brain surgeries, gastroenterology, orthopedics, and joint replacement. The hospital generates revenue through a mix of in-patient and out-patient services, supported by a network of over 30 public and private insurance companies and TPAs. Operations are supported by a robust infrastructure that includes an in-house pharmacy, a pathology laboratory, and advanced medical equipment. The business model is centered on delivering comprehensive and accessible medical care, from emergency services and critical care to specialized treatments, to the community in and around the Tier-3 city of Ferozepur.

IPO Price Band
₹96.00 - ₹102.00
Lot Size
1,200 Shares
Bidding Closes
26 Aug 2026
Listing Date
31 Aug 2026
Quick Answer & Highlights

ABH Healthcare IPO GMP Today & Key Takeaways

Last updated: 27 Aug 2026

The Grey Market Premium (GMP) for ABH Healthcare IPO is currently awaiting trading updates (last quote: ₹0). The shares are offered in the price band of ₹96.00 - ₹102.00 per share, with a minimum retail investment of Rs 2,44,800 for 1,200 Shares. Public bidding has closed. The basis of allotment is expected on 27 Aug 2026, ahead of stock exchange listing on 31 Aug 2026.

Key Metric Figure Status / Context
Current GMP ₹0 +0% vs upper band (27 Aug 2026)
Est. Listing Price Est. ₹102 +0.00% Est. Listing Gain
Price Band ₹96.00 - ₹102.00 SME IPO
Retail Minimum Investment ₹2,44,800 2 Lot (1,200 Shares)
Bidding Window 24 Aug 2026 – 26 Aug 2026 Closed
Allotment & Listing Dates Allotment: 27 Aug 2026 Listing: 31 Aug 2026
Will you apply for this IPO?
Is this GMP accurate?
Did you get allotted this IPO?
IPO Details

Complete IPO information

ABH Healthcare IPO Details and Specifications
IPO Open Date 24 Aug 2026
IPO Close Date 26 Aug 2026
IPO Price Band ₹96.00 - ₹102.00
Lot Size 1,200 Shares
Current GMP ₹0
Estimated Listing Gain +0.00%
Issue Size Approx ₹34.98 Cr
Fresh Issue -
Issue Type SME
IPO Listing NSE SME
Retail Quota TBA
Registrar TBA
Overall Subscription 1.44x
Minimum Investment ₹2,44,800
DRHP Draft Prospectus PDF
RHP Draft Prospectus -
Demand Tracker

Subscription Status

ABH Healthcare IPO Subscription Demand Status Breakdown
Category Shares Reserved Shares Applied Subscription (x)
QIB 1.99 16.67 8.37xx
NII 1.71 4.37 0.29xx
Retail 15.29 25.78 1.69xx
Overall Subscription 34.3 46.81 1.44xx
Analysis

IPO Snapshot & Investor Takeaways

At the upper end of its price band, ABH Healthcare is priced at ₹102 per share. With a minimum lot size of 1,200 shares, a retail investor applying for one lot would need approximately ₹2,44,800 to participate in this SME issue.

The latest recorded Grey Market Premium for ABH Healthcare stands at ₹0, implying an estimated listing gain of around 0.00% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.

As of the latest update, ABH Healthcare's IPO was subscribed 1.44x overall, with a category-wise breakdown of Retail 1.69x, QIB 8.37x, NII 0.29x.

Among the strengths highlighted in ABH Healthcare's IPO documents: Doctor-led professional management team with proven execution capabilities.; Track record of delivering quality clinical care by attracting and retaining renowned clinicians..

Investors should also weigh the risk factors ABH Healthcare has disclosed, including: Significant dependency on key personnel, including promoters and healthcare professionals..

A share of ABH Healthcare's issue proceeds is earmarked for Repayment Of Borrowings: 17 (48.60%).

SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.

Timeline

IPO roadmap at a glance

✓
Bidding Opens 24 Aug 2026
✓
Bidding Closes 26 Aug 2026
03
Allotment Next 27 Aug 2026
04
Listing 31 Aug 2026
ABH Healthcare IPO Timeline and Important Dates Schedule
Event / Milestone Scheduled Date Status
Bidding Opens 24 Aug 2026 Completed
Bidding Closes 26 Aug 2026 Completed
Allotment 27 Aug 2026 Next Milestone
Listing 31 Aug 2026 Pending
Grey Market Premium

Daily GMP status

ABH Healthcare IPO Daily Grey Market Premium (GMP) Trend & Price History
Date GMP Change Gain
27 Aug 2026 ₹0.00 - TBA
26 Aug 2026 ₹0.00 - TBA
25 Aug 2026 ₹0.00 - TBA
24 Aug 2026 ₹0.00 - TBA
19 Aug 2026 ₹0.00 - 0.00%
Swipe to see more →
Market Lot

Application size breakdown

ABH Healthcare IPO Market Lot & Application Breakdown
Category Lots Shares Amount
Retail Minimum 2 Lot 2,400 ₹2,44,800
Retail Maximum 2 Lot 2,400 ₹2,44,800
S-HNI Minimum 3 Lot 3,600 ₹3,67,200
S-HNI Maximum 8 Lot 9,600 ₹9,79,200
B-HNI Minimum 9 Lot 10,800 ₹11,01,600
Swipe to see more →
Fund Utilization

Objects of the Issue & Official Documents

  • Repayment Of Borrowings 17 (48.60%)
  • Working Capital 5 (14.29%)
  • General Corporate Purpose 12.98 (37.11%)
Issue Notes

Important takeaways before applying

Strengths

  • Doctor-led professional management team with proven execution capabilities.
  • Track record of delivering quality clinical care by attracting and retaining renowned clinicians.
  • Diversified operations across multiple clinical specialties, payor mix, and hospitals.
  • Robust operating infrastructure, including modern information technology and medical equipment.
  • Consistent track record of stable operating and financial performance and growth.

Risks

  • Significant dependency on key personnel, including promoters and healthcare professionals.
  • Revenues are significantly dependent on a single hospital located in Ferozepur, Punjab.
  • Inability to keep pace with technological changes and new equipment may adversely affect business.
  • Business is subject to legal claims and regulatory actions arising from healthcare services.
  • The company does not own the premises for its hospital, which operates on a leasehold basis.
Analysis

ABH Healthcare IPO Reservation

The ABH Healthcare IPO reservation is divided among Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail Individual Investors and other applicable categories.

As per the provided allocation, 1,99,200 shares are offered to Qualified Institutional Buyers excluding anchor investors. The NII category is allocated 15,28,800 shares, representing approximately 44.58%, while Retail Individual Investors are also offered 15,28,800 shares, representing approximately 44.58% of the issue.

Investor Category Shares Offered Shares (%)
Anchor Investor – Shares -%
QIB (Ex. Anchor) 1,99,200 Shares -%
NII Shares Offered 15,28,800 Shares 44.58%
Retail Shares Offered 15,28,800 Shares 44.58%
Note: The exact percentage allocation for the QIB (Ex. Anchor) category is not available in the provided data. The table therefore retains the supplied share allocation without estimating the missing percentage.
Analysis

ABH Healthcare IPO Dates

The ABH Healthcare IPO will open for subscription on August 24, 2026 and close on August 26, 2026. Investors can submit their IPO applications during this three-day subscription period.

The ABH Healthcare IPO allotment is expected to be finalized on August 27, 2026. Refunds for unsuccessful applicants and credit of shares to successful investors' demat accounts are scheduled for August 28, 2026. The shares are scheduled to list on the NSE SME platform on August 31, 2026.

IPO Event Date
IPO Open Date August 24, 2026
IPO Close Date August 26, 2026
Basis of Allotment August 27, 2026
Refunds August 28, 2026
Credit to Demat Account August 28, 2026
IPO Listing Date August 31, 2026
Note: The above table summarizes the ABH Healthcare IPO timeline, including the opening date, closing date, basis of allotment, refund initiation, demat credit and proposed NSE SME listing date.
Analysis

ABH Healthcare IPO Dates

Particular Dates
IPO Open Date 24 Aug 2026
IPO Close Date 26 Aug 2026
Basis of Allotment 27 Aug 2026
Refunds -
Credit to Demat Account -
IPO Listing Date 31 Aug 2026

Note: The timeline for ABH Healthcare IPO is tentative and subject to change.

Analysis

ABH Healthcare IPO Objects of the Issue & Utilisation of Proceeds

ABH Healthcare proposes to utilise the proceeds from the fresh issue primarily towards repayment or prepayment of existing borrowings and funding the company's working capital requirements. The remaining proceeds are proposed to support inorganic growth opportunities and general corporate purposes.

The company intends to utilise approximately ₹17.00 crores towards repayment or prepayment, in part or full, of certain borrowings. Another ₹4.30 crores is proposed to be utilised towards working capital requirements to support the company's ongoing healthcare operations.

Purpose Amount
Repayment / prepayment, in part or full, of certain borrowings ₹17.00 Cr.
Funding the Company's Working Capital Requirements ₹4.30 Cr.
Funding inorganic growth through unidentified acquisitions and general corporate purposes ₹-
Note: The specified utilisation towards repayment of borrowings and working capital requirements totals approximately ₹21.30 crores. The remaining net proceeds may be utilised towards inorganic growth through unidentified acquisitions and general corporate purposes in accordance with the offer document.
Analysis

ABH Healthcare Objects of the Issue & Utilisation of Proceeds

To Be Updated Soon

Analysis

ABH Healthcare IPO Company Financial Report

ABH Healthcare reported steady revenue growth between FY2024 and FY2026. Revenue increased from ₹41.39 crores in FY2024 to ₹49.32 crores in FY2025 and further reached ₹52.59 crores in FY2026.

The company's profitability improved more significantly over the same period. Profit After Tax (PAT) increased from ₹1.66 crores in FY2024 to ₹5.35 crores in FY2025 and ₹5.64 crores in FY2026. Total assets also expanded from ₹51.35 crores in FY2024 to ₹85.27 crores in FY2026.

Period Ended Revenue Expense PAT Assets
2024 ₹41.39 Cr. ₹39.19 Cr. ₹1.66 Cr. ₹51.35 Cr.
2025 ₹49.32 Cr. ₹41.89 Cr. ₹5.35 Cr. ₹63.90 Cr.
2026 ₹52.59 Cr. ₹44.66 Cr. ₹5.64 Cr. ₹85.27 Cr.
Amount in ₹ Crores: The above table summarizes ABH Healthcare's revenue, expenses, Profit After Tax (PAT) and total assets from FY2024 to FY2026. The reported figures show continued revenue growth along with a notable improvement in profitability and expansion of the company's asset base.
Analysis

ABH Healthcare Company Financials

To Be Updated Soon

Analysis

ABH Healthcare Company Valuation – FY2026

To Be Updated Soon

Analysis

ABH Healthcare IPO Peer Group Comparison

To Be Updated Soon

Comparison

Compare ABH Healthcare IPO with similar IPOs

FAQ

ABH Healthcare IPO FAQs

ABH Healthcare IPO GMP today is Rs 0. Investors can use this GMP along with price band and subscription status for a better IPO review.
ABH Healthcare IPO price band is Rs 96.00 to Rs 102.00. Check the latest issue price, lot size and GMP together before applying.
ABH Healthcare IPO open date is 24 Aug 2026, close date is 26 Aug 2026, and listing date is 31 Aug 2026.
ABH Healthcare IPO lot size is 1,200 shares. The minimum retail investment is Rs 2,44,800.
ABH Healthcare is classified as a SME IPO. This helps investors quickly understand the issue category and exchange segment.
ABH Healthcare IPO subscription status currently shows Retail 1.69x, QIB 8.37x, NII 0.29x, Overall 1.44x.
ABH Healthcare operates a 150-bed multi-specialty tertiary care hospital in Ferozepur, Punjab, under the brand “Anil Baghi Hospital.” The company focuses on providing a wide range of healthcare services, including advanced clinical care across approximately 25 specialties. Core disciplines include cardiac sciences, neurology, minimally invasive spine and brain surgeries, gastroenterology, orthopedics, and joint replacement. The hospital generates revenue through a mix of in-patient and out-patient services, supported by a network of over 30 public and private insurance companies and TPAs. Operations are supported by a robust infrastructure that includes an in-house pharmacy, a pathology laboratory, and advanced medical equipment. The business model is centered on delivering comprehensive and accessible medical care, from emergency services and critical care to specialized treatments, to the community in and around the Tier-3 city of Ferozepur.
ABH Healthcare IPO issue size is 34.98 and the expected allotment date is 27 Aug 2026.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.
Community discussion

Comments

Share a useful question or insight about ABH Healthcare.

Loading comments...

Leave a comment

Your email address will not be published. All comments and replies are reviewed before appearing.

Keep Exploring

Similar Recent IPOs

Related Topics
ABH Healthcare IPOABH Healthcare GMPABH Healthcare IPO GMPABH Healthcare IPO GMP todayABH Healthcare grey market premiumABH Healthcare price bandABH Healthcare subscription statusABH Healthcare allotment statusABH Healthcare listing dateABH Healthcare lot sizeABH Healthcare IPO reviewABH Healthcare IPO listing gain estimateABH Healthcare GMP calculatorABH Healthcare IPO 2026